Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001323:Autoantibodies / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D015331:Cohort Studies; D016207:Cytokines / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D019798:Neopterin / Q000032:analysis; D011336:Probability; D012044:Regression Analysis; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D018180:Thrombomodulin / Q000032:analysis*; D019010:Vascular Cell Adhesion Molecule-1 / Q000032:analysis